Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review
- PMID: 33535618
- PMCID: PMC7867119
- DOI: 10.3390/cancers13030557
Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review
Abstract
Surgery is the mainstay of treatment for localized soft tissue sarcomas (STS). The curative treatment highly depends on complete tumor resection, as positive margins are associated with local recurrence (LR) and prognosis. However, determining the tumor margin during surgery is challenging. Real-time tumor-specific imaging can facilitate complete resection by visualizing tumor tissue during surgery. Unfortunately, STS specific tracers are presently not clinically available. In this review, STS-associated cell surface-expressed biomarkers, which are currently already clinically targeted with monoclonal antibodies for therapeutic purposes, are evaluated for their use in near-infrared fluorescence (NIRF) imaging of STS. Clinically targeted biomarkers in STS were extracted from clinical trial registers and a PubMed search was performed. Data on biomarker characteristics, sample size, percentage of biomarker-positive STS samples, pattern of biomarker expression, biomarker internalization features, and previous applications of the biomarker in imaging were extracted. The biomarkers were ranked utilizing a previously described scoring system. Eleven cell surface-expressed biomarkers were identified from which 7 were selected as potential biomarkers for NIRF imaging: TEM1, VEGFR-1, EGFR, VEGFR-2, IGF-1R, PDGFRα, and CD40. Promising biomarkers in common and aggressive STS subtypes are TEM1 for myxofibrosarcoma, TEM1, and PDGFRα for undifferentiated soft tissue sarcoma and EGFR for synovial sarcoma.
Keywords: CD40; EGFR; IGF-1R; PDGFRα; TEM1; VEGFR-1; VEGFR-2; image guided surgery; near-infra red fluorescence; soft tissue sarcomas.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method.Biomedicines. 2023 Mar 22;11(3):982. doi: 10.3390/biomedicines11030982. Biomedicines. 2023. PMID: 36979961 Free PMC article.
-
Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs.Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1137-1148. doi: 10.1007/s00259-024-06953-x. Epub 2024 Oct 22. Eur J Nucl Med Mol Imaging. 2025. PMID: 39436437 Free PMC article.
-
Immunohistochemical selection of biomarkers for tumor-targeted image-guided surgery of myxofibrosarcoma.Sci Rep. 2020 Feb 19;10(1):2915. doi: 10.1038/s41598-020-59735-4. Sci Rep. 2020. PMID: 32076024 Free PMC article.
-
Advances in image enhancement for sarcoma surgery.Cancer Lett. 2020 Jul 28;483:1-11. doi: 10.1016/j.canlet.2020.03.029. Epub 2020 Apr 2. Cancer Lett. 2020. PMID: 32247870 Review.
-
Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers.J Surg Oncol. 2022 Feb;125(2):239-245. doi: 10.1002/jso.26680. Epub 2021 Sep 29. J Surg Oncol. 2022. PMID: 34586640 Review.
Cited by
-
Cross-species evaluation of fibroblast activation protein alpha as potential imaging target for soft tissue sarcoma: a comparative immunohistochemical study in humans, dogs, and cats.Front Oncol. 2023 Sep 1;13:1210004. doi: 10.3389/fonc.2023.1210004. eCollection 2023. Front Oncol. 2023. PMID: 37727209 Free PMC article.
-
Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method.Biomedicines. 2023 Mar 22;11(3):982. doi: 10.3390/biomedicines11030982. Biomedicines. 2023. PMID: 36979961 Free PMC article.
-
First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas.Mol Cancer Ther. 2025 May 2;24(5):784-795. doi: 10.1158/1535-7163.MCT-24-0378. Mol Cancer Ther. 2025. PMID: 39686611 Free PMC article.
-
Intraoperative Near-Infrared Fluorescence Imaging with Indocyanine Green for Identification of Gastrointestinal Stromal Tumors (GISTs), a Feasibility Study.Cancers (Basel). 2022 Mar 18;14(6):1572. doi: 10.3390/cancers14061572. Cancers (Basel). 2022. PMID: 35326721 Free PMC article.
-
Introducing Fluorescence-Guided Surgery for Pediatric Ewing, Osteo-, and Rhabdomyosarcomas: A Literature Review.Biomedicines. 2021 Oct 4;9(10):1388. doi: 10.3390/biomedicines9101388. Biomedicines. 2021. PMID: 34680505 Free PMC article. Review.
References
-
- Vos M., Blaauwgeers H.G.T., Ho V.K.Y., van Houdt W.J., van der Hage J.A., Been L.B., Bonenkamp J.J., Bemelmans M.H.A., van Dalen T., Haas R.L., et al. Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: A nationwide study from the Netherlands. Eur. J. Cancer. 2019;110:98–106. doi: 10.1016/j.ejca.2019.01.005. - DOI - PubMed
-
- WHO Classification of Tumours . Tissue and Bone Tumours: WHO Classification of Tumours. 5th ed. Volume 3 IARC Publications; Lyon, France: 2020.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous